I was inspired to be a scientist because of my immense interest in the complexities and intricacies of the human body. The focus of my Ph.D. was on elucidating signaling pathways in the context of development, specifically the Notch pathway. In my current role I am excited to utilize my passion and channel it toward signaling in a disease and therapeutic context.
Some of the challenges in lymphoma treatment protocols include drug toxicities that cause debilitating side effects, and suboptimal antitumor efficacy. To overcome this and improve the therapeutic window, my aim is to identify and validate novel drug combinations using mechanistic preclinical data.
My projects involve investigating combinations of BCL2 family members as more efficacious therapeutics for lymphoma. I am particularly interested in identifying novel methods of drug delivery to tumors.